| J9271 | Injection, pembrolizumab, 1 mg | 14,210 | $40 | $610.8K |
| J0897 | Injection, denosumab, 1 mg | 5,520 | $20 | $99.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $44.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $100 | $31.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 510 | $60 | $30.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 90 | $120 | $10.3K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $130 | $9.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 190 | $50 | $9K |
| J1750 | Injection, iron dextran, 50 mg | 660 | $10 | $8.6K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 300 | $20 | $6.7K |